Randomized, multicentre, double-blind, parallel-group clinical study of Bimatoprost in patients with glaucoma or ocular hypertension.

Trial Profile

Randomized, multicentre, double-blind, parallel-group clinical study of Bimatoprost in patients with glaucoma or ocular hypertension.

Completed
Phase of Trial: Phase III

Latest Information Update: 10 May 2017

At a glance

  • Drugs Bimatoprost (Primary) ; Timolol
  • Indications Glaucoma; Ocular hypertension
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 May 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top